Access to Medicine

UNAIDS PCB 39: Statement of India on the Executive Director’s Report to the 39th PCB

Posted on by Thiru

On Tuesday, 6 December 2016, the delegation of India delivered the following intervention at the 39th UNAIDS Programme Coordinating Board (PCB) Meeting.

India declared that she had “recently crossed the milestone of treating 1 million HIV patients with free Anti-Retroviral Therapy (ART).”

I will first briefly share efforts made by India to implement the Fast track Strategy. A number of major policy decisions have been taken recently towards achieving the 90-90-90 targets.

Continue Reading →

9 November 2016 – WTO TRIPS Council – Holy See’s statement on the Report of the UN High-Level Panel on Access to Medicines

Posted on by Thiru

On Wednesday, 9 November 2016, H.E. Archbishop Ivan Jurkovic, (Holy See) delivered the following statement at the World Trade Organization’s (WTO) TRIPS Council’s discussions of the United Nations Secretary-General’s High Level Panel Report on Access to Medicines

Statement by H.E. Archbishop Ivan Jurkovic , Permanent Observer of the Holy See to the United Nations and Other International Organizations in Geneva at the World Trade Organization (WTO) Trade Related Intellectual Property Rights (TRIPs) Council, Geneva, 9 November 2016

Mr. President,

Continue Reading →

9 November 2016 – WTO TRIPS Council – EU’s intervention on the Report of the UN High-Level Panel on Access to Medicines

Posted on by Thiru

On Wednesday, 9 November 2016, the European Union delivered the following statement at the World Trade Organization’s (WTO) TRIPS Council’s discussions of the United Nations Secretary-General’s High Level Panel Report on Access to Medicines.

UNITED NATIONS SECRETARY-GENERAL’S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES

The European Commission takes note of the contribution provided by the Report of the United Nations Secretary-General’s High-Level Panel on Access to Medicines.

Continue Reading →

9 November 2016 – WTO TRIPS Council – UNCTAD’s statement on the Report of the UN High-Level Panel on Access to Medicines

Posted on by Thiru

On Wednesday, 9 November 2016, the United Nations Conference on Trade and Development (UNCTAD) delivered the following statement at the World Trade Organization’s (WTO) TRIPS Council’s discussions of the United Nations Secretary-General’s High Level Panel Report on Access to Medicines. UNCTAD informed WTO members that the agency had recently recommended to Secretary-General Ban Ki-moon to consider endorsement of the Report of the High Level Panel.

The Report of the United Nations High Level Panel on Access to Medicine
Continue Reading →

9 November 2016 – WTO TRIPS Council – India’s intervention on the Report of the UN High-Level Panel on Access to Medicines

Posted on by Thiru

On Wednesday, 9 November 2016, India delivered the following statement at the World Trade Organization’s (WTO) TRIPS Council’s discussions of the United Nations Secretary-General’s High Level Panel Report on Access to Medicines.

Agenda item 13: the United Nations Secretary-General’s High Level Panel Report on Access to Medicines

Statement by India.

Thank you Chairman.

At the outset, I would like to thank delegations of Brazil, China and South Africa who are also co-sponsors of this agenda item.

Continue Reading →

9 November 2016 – WTO TRIPS Council – WHO’s intervention on the Report of the UN High-Level Panel on Access to Medicines

Posted on by Thiru

On Wednesday, 9 November 2016, the World Health Organization (WHO) delivered the following statement at the World Trade Organization’s (WTO) TRIPS Council’s discussions of the United Nations Secretary-General’s High Level Panel Report on Access to Medicines.

COUNCIL FOR TRIPS

8-9 NOVEMBER 2016

WHO STATEMENT

13. THE UNITED NATIONS SECRETARY-GENERAL’S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES

Thank you very much for giving WHO the opportunity to share our feedback on the Report of the High-Level Panel on Access to Medicines.

Continue Reading →

9 November 2016 – WTO TRIPS Council – Brazil’s intervention on the Report of the UN High-Level Panel on Access to Medicines

Posted on by Thiru

On 9 November 2016, the World Trade Organization’s (WTO) TRIPS Council held discussions on the United Nations Secretary-General’s High-Level Panel Report on Access to Medicines (UN HLP). These timely WTO discussions on the UN HLP germinated from a 27 October 2016 request by Brazil, China, India and South Africa requesting the WTO Secretariat to place a dedicated agenda item for consideration at the 8-9 November 2016 session of the TRIPS Council entitled “the United Nations Secretary-General’s High-Level Panel Report on Access to Medicines.”

Continue Reading →

WTO TRIPS Council – Brazil, China, India and South Africa request discussion of the UN High-Level Panel on Access to Medicines

Posted on by Staff

On Thursday, 27 October 2016, Brazil, China, India and South Africa submitted a communication (IP/C/W/619) to the World Trade Organization (WTO) requesting the WTO Secretariat to “place a dedicated agenda item for consideration at the 8-9 November 2016 session of the TRIPS Council entitled “the United Nations Secretary-General’s High-Level Panel Report on Access to Medicines.” In the WTO submission, Brazil, China, India and South Africa enclosed the entire Final Report of the UN Secretary-General’s High-Level Panel on Access to Continue Reading →

2016: Kite Pharma, KEI Comments on NIH Proposed Exclusive License for Cancer Treatment

Posted on by Claire Cassedy

Today, KEI submitted comments to the Notice published in the Federal Register on October 5, 2016, entitled “Prospective Grant of Exclusive Patent License: Development of Anti-CD70 Chimeric Antigen Receptors for the Treatment of CD70 Expressing Cancers.” KEI’s comments addressed issues with the NIH’s processes for granting exclusive licenses, and transparency in those licenses, resulting data, trials, pricing, and revenue.
Continue Reading →